Yüklüyor......
Precision therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a molecularly and clinically heterogeneous disease. Despite advances in understanding the pathogenesis of AML, the standard therapy remained nearly unchanged over the past three decades. With the poor survival for older patients and high relapse rate, multiple studies...
Kaydedildi:
| Yayımlandı: | J Hematol Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5755341/ https://ncbi.nlm.nih.gov/pubmed/29301553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0543-7 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|